OTC Markets OTCQB - Delayed Quote USD
NUREXONE BIOLOGIC INC (NRXBF)
At close: 12:04 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,757.0000
-2,941.0000
-3,848.0000
-1,232.0000
Investing Cash Flow
-355.0000
-97.0000
-89.0000
-19.0000
Financing Cash Flow
5,583.0000
1,132.0000
4,295.0000
3,463.0000
End Cash Position
2,351.0000
541.0000
2,463.0000
2,214.0000
Capital Expenditure
-368.0000
-120.0000
-52.0000
--
Issuance of Capital Stock
1,306.0000
740.0000
2,331.0000
2,226.0000
Issuance of Debt
--
--
111.0000
1,119.0000
Repayment of Debt
-34.0000
-28.0000
-15.0000
--
Free Cash Flow
-4,125.0000
-3,061.0000
-3,900.0000
-1,232.0000
12/31/2021 - 11/10/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SABSW SAB Biotherapeutics, Inc.
0.0534
+6.80%
RNXT RenovoRx, Inc.
1.0000
0.00%
BVAXF BioVaxys Technology Corp.
0.0485
+21.86%
PBMWW Psyence Biomedical Ltd.
0.0208
-47.74%
LIPO Lipella Pharmaceuticals Inc.
0.4760
-2.78%
TSOI Therapeutic Solutions International, Inc.
0.0007
0.00%
DRTS Alpha Tau Medical Ltd.
2.2100
-1.78%
TTNP Titan Pharmaceuticals, Inc.
4.3300
-4.20%
SCNI Scinai Immunotherapeutics Ltd.
3.6200
-9.05%
XBIO Xenetic Biosciences, Inc.
3.6300
-2.68%